New drug for rare childhood disease; price tag, $702,000 a year
And an explosive statement from the FDA
by Jon Rappoport
May 1, 2017
by Jon Rappoport
The FDA has just approved a new drug, Brineura, for a rare childhood brain-disease known as CLN2, which progresses quickly and is considered fatal.